))
Venture Capital Perspectives: Early Stage Biotech Investing
Manage episode 154229731 series 1116730
Contenido proporcionado por Columbia Tech Ventures and Columbia Technology Ventures. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Columbia Tech Ventures and Columbia Technology Ventures o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Presenting a discussion and Q&A with Doug Cole, managing partner of Flagship Ventures, a life science venture fund with over $1.4 billion under management and a new $574 million fund devoted to early-stage therapeutics, health technologies and sustainability. In an interview with CTV’s Executive Director Orin Herskowitz, Doug discusses Flagship Ventures’ perspective on opportunities and challenges within the venture investment landscape, current trends, past experiences with early-stage investing, its VentureLabs Fellows program, and building a career as a venture capitalist.
…
continue reading
15 episodios
Compartir
